InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,903.90
(
2.09%
)
US TECH 100
20,121.61
(
2.20%
)
Dow Jones
43,578.37
(
3.21%
)
Brent Oil
75.19
(
-0.27%
)
Bitcoin
74,499.68
(
7.48%
)
Post# of 430225
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Whalatane

Send PM Follow Ignore
Followers 127
Posts 21266
Boards Moderated 0
Alias Born 06/13/2011

Whalatane

Member Level

Re: Atom0aks post# 224084

Sunday, 11/10/2019 12:26:43 PM

Sunday, November 10, 2019 12:26:43 PM

Post# of 430225
Atom ..well I think you have that wrong .

Amarin will not ask for a primary prevention label ---except for that subgroup of primary prevention patients that are diabetic etc .and were included in R-IT .

R-IT did not include a vast number of non diabetic primary prevention patients ...so Amarin has no data to base a claim for that label .

In reality ...once approved ...many primary prevention patients on statins with family history and TG's still above 135 mg/dl ...will get scripts for all the reasons JL has explained

JMO
Kiwi
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent AMRN News
More AMRN News
InvestorsHub NewsWire

VAYK Confirms Insider Buying at Open Market • VAYK • Nov 5, 2024 10:40 AM

Rainmaker Worldwide Inc. Announces Strategic Partnership Between Miranda Water Technologies and Fleming College • RAKR • Nov 4, 2024 12:03 PM

North Bay Resources Announces Assays up to 9.5% Copper at Murex Copper Project, British Columbia • NBRI • Nov 4, 2024 9:00 AM

Rainmaker Worldwide Inc. to Assume Direct, Non-Dealer Sales of Miranda Water Technologies in U.S. and Mexico in First Quarter of 2025 • RAKR • Nov 4, 2024 8:31 AM

CBD Life Sciences Inc. (CBDL) Launches High-Demand Mushroom Gummy Line for Targeted Wellness Needs, Tapping into a Booming $20 Billion Market • CBDL • Oct 31, 2024 8:00 AM

Nerds On Site Announces Q1 Growth and New Initiatives for the Remainder of 2024 • NOSUF • Oct 31, 2024 7:01 AM

Start posting your company's news
Only $200 per official company press release!